Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Tax (Details) - Schedule of deferred income taxes

v3.21.1
Income Tax (Details) - Schedule of deferred income taxes - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Schedule of deferred income taxes [Abstract]        
Net operating loss carry forward $ 13,170 $ 12,607    
Research and development expenses 820 801    
Valuation of financial instruments (10)      
Less – valuation allowance (13,980) (13,408) $ (10,923) $ (11,155)
Net deferred tax assets